Home OrganaBio

OrganaBio

In operation
-
Cell and Gene Therapy Product Manufacturer
Basic
Enterprise Profile

Basic Information

OrganaBio's proprietary supply chain provides customers with mission-critical resources: from progenitor and immune cells derived from birth tissue, to a full suite of expert services and flexible cGMP manufacturing solutions.Limitations in infrastructure and supply chains have consistently hindered the life sciences industry from delivering cutting-edge therapies to patients. OrganaBio’s corporate philosophy is built on the premise that control, quality, and redundancy in the supply chain ultimately determine the success of any program. OrganaBio's network of physicians grants it access to fresh cesarean section tissues, enabling the company to produce the highest quality starting materials for cell, gene, and immune therapies.
OrganaBio, LLC
Miami,Florida,United States of America
15~50 people
January 01, 2018
--

Enterprise Profile

Industrial Sector
Compound Discovery Compound Design New Drug Development Biological Product Manufacturing CRO CDMO
Technology
Gene Technology Cell Technology
Concept
Adjuvant Therapy Products
Application Scenarios
Biological Products